Prosecution Insights
Last updated: April 19, 2026
Application No. 18/258,683

LUBRICANT COMPOSITION

Non-Final OA §103
Filed
Jun 21, 2023
Examiner
OLADAPO, TAIWO
Art Unit
1771
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Idemitsu Kosan Co. Ltd.
OA Round
5 (Non-Final)
53%
Grant Probability
Moderate
5-6
OA Rounds
3y 2m
To Grant
64%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allow Rate
605 granted / 1144 resolved
-12.1% vs TC avg
Moderate +11% lift
Without
With
+11.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
89 currently pending
Career history
1233
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
52.8%
+12.8% vs TC avg
§102
16.2%
-23.8% vs TC avg
§112
15.9%
-24.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1144 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . The amendment dated 12/12/2025 has been considered and entered. The amendment which requires the presence of the thiadiazole at 0.27% or higher in the composition overcomes the rejections in view of Susukida et al. (US 2020/0332218) which recites amounts of up to 0.2% of the thiadiazole. Therefore, the previous rejections are withdrawn. Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 12/12/2025 has been entered. Claim Interpretation The claim recites the presence of a base oil such as mineral or synthetic oil, wherein the synthetic oil is other than an ester synthetic oil, etc., which is understood to imply that when the base oil is synthetic oil alone, it must “also” contain a non-ester synthetic oil. This therefore does not teach away from the presence of ester synthetic oils, but requires that ester synthetic oil cannot be the only base oil present. The claim rejections in view of Masuda et al. (US 2017/0145337) which were previously withdrawn in the office action dated 10/18/2024 for reciting the presence of an ester synthetic oil are reapplied. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1, 3 – 8, 12 – 24 are rejected under 35 U.S.C. 103 as being unpatentable over Masuda et al. (US 2017/0145337) in view of Sunagawa (US 2019/0119597) In regards to claim 1, Masuda teaches lubricating oil composition for transmissions, gears, etc. [0118]. The composition can comprise mineral base oil having a kinematic viscosity at 100℃ (Kv100) of 1.5 mm2/s (cSt) to 20 mm2/s (cSt) [0012]. The mineral oils can be hydrocracked oils (Group II), GTL oil (Group III) according to limitation A of the claim [0035 – 0039]. The composition can comprise a sulfur-containing phosphite which is a phosphorus acid ester according to limitation C of the claim [0013]. The phosphorus compounds comprise a single sulfur atom and since the mol ratio of the phosphorus and sulfur are 1:1 and the molecular weights are about the same, the sulfur content from the phosphite would be similar to the phosphorus concentration of from close to about 150 ppm to 400 ppm [0077 – 0082]. The composition comprises a polysulfide (i.e., sulfurized olefin) or a thiadiazole component according to the limitation B of the claim [0083]. Thus, sulfurized olefin can be absent from the composition. The thiadiazole has structures (4) to (6) [0095]. The additives can be present at preferably from 0.1 to 20% [0107]. In the examples, the composition has Kv100 of 2.8 cSt or 3.3 cSt and comprises thiadiazole at 0.15% in the composition [Table 1]. Masuda does not particularly recite the amount of the thiadiazole as claimed. Sunagawa is added to similarly teach gear oils having thiadiazoles which can be present in the oil at amount of from 0.1 to 10% in the composition [0059]. Thus, it would have been obvious for persons of ordinary skill in the art at the time the claim was filed to have used thiadiazole in the amounts recited by Sunagawa in the composition of Masuda, as Sunagawa teaches suitable amount of thiadiazole for use in gear oils. In regards to claim 3, Masuda teaches the composition which comprises the thiadiazole with alkyl groups having from 1 to 30 carbon atoms [0096]. Alkyl groups can be either straight or branched and thus branched alkyl groups are obvious. In regards to claims 4 – 6, Masuda teaches the composition having the claimed structures as previously stated. The structures b-1, b-2, b-3, b-4 and b-5 are tautomers and are thus similar and/or identical structures. Tautomerism allows double bonds in cyclic groups to move around within a structure. In regards to claims 7, 8, Masuda in view of Sunagawa teaches the composition having the thiadiazole in the claimed amounts as previously stated. In regards to claim 12, Masuda teaches composition useful as gear oils which are useful for lubricating gears as previously stated. Gears provide the limitation of speed reducer. In regards to claim 13, Masuda teaches gear oils having the claimed composition and thus when the composition is applied to gears, the method of lubricating a speed reducer is intrinsically performed. In regards to claim 14, Masuda teaches the composition having the claimed ingredients with the claimed limitations and thus provides the method for producing the composition as claimed, wherein when the ingredients are mixed into the oil to provide the claimed limitations, the claimed method is intrinsically performed. In regards to claim 15, Masuda teaches the composition which does not require the presence of the sulfurized olefin as previously stated. In regards to claims 16, 17, Masuda in view of Sunagawa teaches the composition. Masuda teaches the mineral base oil can be present at from 50 to 97%, 3 to 10% of a monoester base oil, and the phosphite that provides phosphorus in amounts of from 150 to 400 ppm (abstract, claims). The optional thiadiazole can be present at minor amounts as previously discussed. Since the monoester can be present at from 3 to 10%, the other ingredients would be present in the claimed amounts. In regards to claim 18, Masuda in view of Sunagawa teaches the amounts of the base oil, thiadiazole, phosphite providing phosphorus at from 150 to 400ppm and other additive(s) as previously stated. Masuda exemplifies the use of phosphites such as 1,3- thio-pentyl-hydrogen phosphite (i.e., 1,3-dithio-pentyl-hydrogen phosphite) which is calculated to comprise about 11% phosphorus, stoichiometrically (table 1). Thus, when the phosphorus compound is used to provide 150 to 400 ppm of phosphorus, it would be present in the composition at calculated amounts of from about 0.14% to about 0.36% in the composition. In regards to claim 19, Masuda teaches the composition having the sulfur containing phosphorus acid ester (phosphite). In regards to claims 20, 24, Masuda in view of Sunagawa teaches the composition having the claimed limitations as previously stated. In regards to claims 21 – 23, Masuda teaches the claimed limitations as previously stated. Response to Arguments Applicant’s arguments with respect to have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to TAIWO OLADAPO whose telephone number is (571)270-3723. The examiner can normally be reached 8-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Prem Singh can be reached at 571-272-6381. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /TAIWO OLADAPO/Primary Examiner, Art Unit 1771
Read full office action

Prosecution Timeline

Jun 21, 2023
Application Filed
Jun 21, 2023
Response after Non-Final Action
May 13, 2024
Non-Final Rejection — §103
Aug 14, 2024
Response Filed
Oct 14, 2024
Final Rejection — §103
Mar 18, 2025
Request for Continued Examination
Mar 20, 2025
Response after Non-Final Action
Apr 03, 2025
Non-Final Rejection — §103
Jul 01, 2025
Response Filed
Sep 10, 2025
Final Rejection — §103
Dec 12, 2025
Request for Continued Examination
Dec 17, 2025
Response after Non-Final Action
Jan 20, 2026
Non-Final Rejection — §103
Apr 16, 2026
Applicant Interview (Telephonic)
Apr 16, 2026
Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12590262
ANTI-FRICTION COMPOSITE MATERIAL
2y 5m to grant Granted Mar 31, 2026
Patent 12590263
LUBRICANT ADDITIVE, LUBRICANT COMPOSITION, AND WORKING FLUID COMPOSITION
2y 5m to grant Granted Mar 31, 2026
Patent 12584078
Method for Producing Lubricating Greases of Lithium Complex Soaps and Lithium-Calcium-Complex Soaps
2y 5m to grant Granted Mar 24, 2026
Patent 12570911
A MARINE FUEL BLEND
2y 5m to grant Granted Mar 10, 2026
Patent 12571073
ALUMINUM BRONZE ALLOY AND SLIDING MEMBER USING SAID ALLOY
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
53%
Grant Probability
64%
With Interview (+11.4%)
3y 2m
Median Time to Grant
High
PTA Risk
Based on 1144 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month